Program Book - Confex

ACR/ARHP Poster Session C
2258. sIL-7R Is a Novel Marker of Disease Activity in SLE
Nephritis, Which Reflects Target Organ Involvement.
Valérie Badot 1 , Geneviève Depresseux 2 , Frédéric. A.
Houssiau 2 and Bernard Lauwerys 2 , 1 CHU-Brugmann &
Université catholique de Louvain, Brussels, Belgium,
2
Université catholique de Louvain, Brussels, Belgium
2259. High-Sensitivity C-Reactive Protein As An Independent
Risk Factor for Coronary Artery Disease in Systemic Lupus
Erythematosus. Mandana Nikpour 1 , Dafna D. Gladman 2 ,
Dominique Ibanez 3 , Paula Harvey 4 and Murray B. Urowitz 3 ,
1
The University of Melbourne, Fitzroy, Australia, 2 Toronto
Western Hospital, University of Toronto, Toronto, ON,
3
Toronto Western Hospital and University of Toronto,
Toronto, ON, 4 Women’s College Hospital, Toronto, ON
2260. Effect of Raloxifene, a Selective Estrogen Receptor
Modulator, on Disease Activity, Flare and Vascular
Biomarkers in Patients with Systemic Lupus Erythematosus
(SLE): A 12-Month Double-Blinded Randomized Controlled
Trial. Chi Chiu Mok 1 , King Yee Ying 2 and Kwok Man Ma 1 ,
1
Tuen Mun Hospital, Hong Kong, Hong Kong, 2 Princess
Margaret Hospital, Hong Kong, Hong Kong
2261. Transcriptional Patterns in Whole Blood Diagnostic of
Systemic Lupus Erythematosus. Tracy Costello and Cole
Harris, Exagen Diagnostics, Houston, TX
2262. Adjusted Framingham Risk Factor Scoring for Systemic
Lupus Erythematosus. Murray B. Urowitz 1 , Dominique
Ibanez 1 and Dafna D. Gladman 2 , 1 Toronto Western Hospital
and University of Toronto, Toronto, ON, 2 Toronto Western
Hospital, University of Toronto, Toronto, ON
2263. Damage Accrual in Patients with Systemic Lupus
Erythematosus Is Associated with Endothelial Function
Detriment: A Prospective Cohort Study. Chiara Tani 1 , R.
Bruno 1 , Anna d’Ascanio 2 , Lorenzo Ghiadoni 1 , Y. Plantinga 1 ,
Rossella Neri 1 , Antonio Tavoni 3 , Linda Carli 1 , Stefano Taddei 1 ,
Stefano Bombardieri 2 and Marta Mosca 1 , 1 University of Pisa,
Pisa, Italy, 2 Rheumatology Unit, Pisa, Italy, 3 AOUP, Pisa, Italy
2264. Transverse Myelitis and Its Relationship with Neuromyelitis
Optica in the Michigan Lupus Cohort. Malini Venkatram 1 ,
Patricia C. Cagnoli 1 , Diana Gomez-Hassan 2 and W. Joseph
McCune 1 , 1 University of Michigan, Ann Arbor, MI, 2 Univ of
Michigan, Ann Arbor, MI
2265. Evaluation of Treatment Success in Systemic Lupus
Erythematosus Clinical Trials: Development of the British
Isles Lupus Assessment Group-Based Composite Lupus
Assessment Endpoint. D. Wallace 1 , V. Strand 2 , R. Furie 3 ,
M. Petri 4 , K. Kalunian 5 , M. Pike 6 , L. Kelley 7 and C. Gordon 8 ,
1
Cedars-Sinai Medical Center, Los Angeles, CA, 2 Stanford
University, Palo Alto, CA, 3 North Shore-LIJ Health System,
Lake Success, NY, 4 Johns Hopkins University School of
Medicine, Baltimore, MD, 5 UCSD School of Medicine, La
Jolla, 6 Massachusetts General Hospital, Fort ashington, PA,
7
UCB, Symrna, GA, 8 Medical School, Birmingham, United
Kingdom
2266. Inpatient Mortality Related to Cerebrovascular Disease
in Systemic Lupus Erythematosus: The Impact of Delay in
Diagnosis of Neuropsychiatric Lupus. Jamal A. Mikdashi,
Univ of Maryland Schl of Med, Baltimore, MD
2267. Predictors of Outcome in Peripheral Nervous System
Manifestations of Systemic Lupus Erythematosus. Brandusa
Florica 1 , Jiandong Su 2 and Paul R. Fortin 1 , 1 Toronto Western
Hospital, Toronto, ON, 2 The Toronto Western Hospital,
Toronto, ON
2268. Mortality Causes and Associated Factors in a Systemic
Lupus Erythematosus Monocentric Cohort: Is the Systolic
Pulmonary Artery Pressure A Risk Factor for Death I. Rua-
Figueroa, C. Erausquin, MD Fiuza, F. Francisco-Hernández, S.
Ojeda, A. Naranjo, JC Quevedo, A. Acosta, R. Lopez -R and C.
Rodriguez-Lozano, Hospital de GC Dr Negrin, Las Palmas GC,
Spain
2269. Anti-Nucleosome Antibodies Correlate with Temporal
Fluctuations in Disease Activity in Systemic Lupus
Erythematosus. Li Timothy 1 , Stacey Morrison 2 , Wendy
Lou 3 , Heather Reich 2 , Ellie Aghdassi 4 , D. D. Gladman 5 ,
Murray B. Urowitz 1 , James Scholey 2 , Paul R. Fortin 1 , Joan
E. Wither 6 and Carolina Landolt-Marticorena 1 , 1 Toronto
Western Hospital and University of Toronto, Toronto, ON,
2
The Toronto Western Hospital, Toronto, ON, 3 University of
Toronto, Toronto, ON, 4 University Health Network, Toronto,
ON, 5 The Arthritis Program, Toronto Western Hospital
and Division of Rheumatology, Toronto Western Hospital
and University of Toronto, Toronto, ON, 6 Toronto Western
Research Institute, University Health Network, Toronto, ON
2270. The Substantial Negative Impact of Systemic Lupus
Erythematosus on the Working Lives of Patients: Results
of the Lupus European Online Survey. M. Schneider 1 ,
C. Gordon 2 , K. Lerstrøm 3 , M. Govoni 4 , E. Nikai 4 and D.A.
Isenberg 5 , 1 Heinrich-Heine-University, Duesseldorf,
Germany, 2 University of Birmingham, Birmingham, United
Kingdom, 3 LUPUS EUROPE, Farum, Denmark, 4 UCB, Brussels,
Belgium, 5 University College of London, London, United
Kingdom
2271. Is the Heightened Lung Cancer Risk in SLE Decreasing Over
Time Data From a Very Large International Multi-Centre
Cohort. Sasha Bernatsky 1 , Ann E. Clarke 2 , C. Gordon 3 , Jeremy
Labrecque 1 , Rosalind Ramsey-Goldman 4 and Systemic
Lupus International Collaborating Clinic (SLICC). 5 , 1 McGill
UHC/RVH, Montreal, QC, 2 Research Institute of the McGill
Univ. Health, Montreal, QC, 3 University of Birmingham,
Birmingham, United Kingdom, 4 Northwestern University
Feinberg School of Medicine, Chicago, IL, 5 Toronto
2272. Risk Factors Associated with Cataracts in SLE Patients.
An Inception-Cohort Study. Mariana Chávez-Villa, Juanita
Romero-Diaz, Claudia Recillas-Gispert, Carmen Lizana,
Francisco Cárdenas and Jorge Sánchez-Guerrero, Instituto
Nacional de Ciencias Medicas y Nutrición Salvador Zubirán,
Mexico, Mexico
292
2011 Program Book